Actinic Keratosis Market Report 2026

Actinic Keratosis Market Overview

• Actinic Keratosis market size has reached to $8.42 billion in 2025 • Expected to grow to $11.06 billion in 2030 at a compound annual growth rate (CAGR) of 5.6% • Growth Driver: Rising Cases Of Severe Sunburns Fueling The Prevalence Of Actinic Keratosis • Market Trend: Advancements In Topical Therapies For Precancerous Skin Lesions • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Actinic Keratosis Market?

Actinic keratosis (AK), also known as solar keratosis, is a common precancerous skin condition that occurs due to prolonged exposure to ultraviolet (UV) radiation from the sun or artificial sources leading to rough, scaly or crusty patches on sun-exposed areas of the skin such as the face, scalp, hands and arms. It is considered an early stage of squamous cell carcinoma (SCC) and requires treatment to prevent progression. Regular skin checks and protection from sun exposure are essential for managing and preventing the development of actinic keratosis. The main types of treatment in the actinic keratosis are topical treatment, surgical procedure, photodynamic therapy, and others. Topical treatment for actinic keratosis involves creams or ointments applied directly to the affected area of the skin. The various distribution channels include hospital pharmacies, drug stores and retail pharmacies, and online providers, and several end-users encompass hospitals, dermatology clinics, spas and rejuvenation centers, homecare settings, and others.

What Is The Actinic Keratosis Market Growth Forecast?

The actinic keratosis market size is expected to see strong growth in the next few years. It will grow to $11.06 billion in 2030 at a compound annual growth rate (CAGR) of 5.6%. The growth in the forecast period can be attributed to development of advanced photodynamic therapies, increasing use of combination topical and procedural treatments, expansion of hospital and dermatology clinic networks, rising consumer awareness of early intervention, introduction of innovative homecare treatment solutions. Major trends in the forecast period include increasing awareness about sun protection and skin health, rising adoption of non-invasive photodynamic therapy, growth in topical therapeutics usage for early-stage ak, expansion of dermatology clinics and homecare treatments, increasing preference for combination therapies.

Global Actinic Keratosis Market Segmentation

1) By Treatment Type: Topical Treatment, Surgical Procedure, Photodynamic Therapy, Other Treatment Types 2) By Distribution Channels: Hospital Pharmacies, Drug Stores And Retail Pharmacies 3) By End-User: Hospitals, Dermatology Clinics, Homecare Settings, Other End-Users Subsegments: 1) By Topical Treatment: 5-Fluorouracil (5-FU), Imiquimod, Diclofenac 2) By Surgical Procedure: Cryotherapy, Curettage And Electrodessication 3) By Photodynamic Therapy: Aminolevulinic Acid (ALA) Plus Light Therapy, Methyl Aminolevulinate (MAL) Plus Light Therapy 4) By Other Treatment Types: Laser Therapy, Combination Therapies

What Is The Driver Of The Actinic Keratosis Market?

The increasing cases of severe sunburns are expected to propel the growth of the actinic keratosis market going forward. Severe sunburns are intense skin burns caused by excessive exposure to ultraviolet (UV) radiation, resulting in redness, pain, swelling, and sometimes blistering. Sunburns are attributed to factors such as prolonged exposure to ultraviolet (UV) radiation, lack of proper sun protection measures, increased outdoor activities during peak UV hours, and rising temperatures due to climate change. Sunburns cause actinic keratosis by damaging the DNA in skin cells through ultraviolet (UV) radiation, leading to mutations that disrupt normal cell function, resulting in the development of precancerous lesions, especially with repeated or prolonged sun exposure. For instance, in May 2024, according to Melanoma Focus, a UK-based charity, in 2022-23, there were 201 hospital admissions due to sunburn, including 89 children and 25 babies under one year old. The charity also found that 66% of UK adults aged 16-65 remembered getting sunburned as children, 65% of them experienced severe sunburn with blisters at least once. This number rose to 77% for those with light, pale, or white skin. Therefore, the increasing cases of severe sunburns is driving the growth of the actinic keratosis industry.

Key Players In The Global Actinic Keratosis Market

Major companies operating in the actinic keratosis market are Galderma SA, LEO Pharma A/S, Almirall S.A., Bausch Health Companies Inc., Perrigo Company plc, Pfizer Inc, F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., Novartis AG, GSK plc, Amgen Inc., Incyte Corporation, Aclaris Therapeutics Inc., Biofrontera AG, Hill Dermaceuticals Inc., Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Viatris Inc.

Global Actinic Keratosis Market Trends and Insights

Major companies operating in the actinic keratosis market are focusing on developing topical ointments to effectively target and eliminate precancerous lesions, reduce recurrence rates, and enhance patient compliance with shorter treatment durations and improved safety profiles. Topical ointments are medicated creams or gels applied directly to the affected skin with active ingredients such as tirbanibulin, which work by targeting abnormal keratinocytes to treat precancerous lesions. For instance, in June 2024, Almirall SA, a Spain-based biopharmaceutical company, received approval from the US Food and Drug Administration (FDA) for a supplemental new drug application (sNDA) to expand the use area for its drug, Klisyri, to up to 100 cm2. Klisyri (tirbanibulin) 1% ointment is a microtubule inhibitor, designed to prevent the proliferation of abnormal keratinocytes, effectively reducing the number and size of precancerous lesions for the treatment of actinic keratosis (AK) on the face or scalp.

What Are Latest Mergers And Acquisitions In The Actinic Keratosis Market?

In June 2024, Sun Pharmaceutical Industries Limited, an India-based pharmaceutical company, merged with Taro Pharmaceutical Industries Ltd. for $454 million. With this merger, Sun Pharmaceutical Industries Limited intends to build on Taro’s expertise in dermatology and pediatrics, along with specialty and generic pharmaceuticals and over-the-counter products. Taro Pharmaceutical Industries Ltd is an Israel-based pharmaceutical company focused on developing and manufacturing dermatology and topical treatment products, including actinic keratosis.

Regional Outlook

North America was the largest region in the actinic keratosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Actinic Keratosis Market?

The actinic keratosis market consists of revenues earned by entities by providing services such as skin cancer screenings, cryotherapy, laser treatments, patient education programs and other medical procedures or products for prevention and management. The market value includes the value of related goods sold by the service provider or included within the service offering. The actinic keratosis market also includes sales of cryosurgery devices, laser treatment systems, and sunscreen products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Actinic Keratosis Market Report 2026?

The actinic keratosis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the actinic keratosis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.